Cargando…

Novel GANAB variants associated with polycystic liver disease

BACKGROUND: Polycystic liver disease (PLD) is an inherited disorder characterized by numerous cysts in the liver. Autosomal dominant polycystic kidney and liver disease (ADPKD and ADPLD, respectively) have been linked to pathogenic GANAB variants. GANAB encodes the α-subunit of glucosidase II (GIIα)...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Laarschot, Liyanne F. M., te Morsche, René H. M., Hoischen, Alexander, Venselaar, Hanka, Roelofs, Hennie M., Cnossen, Wybrich R., Banales, Jesus M., Roepman, Ronald, Drenth, Joost P. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585303/ https://www.ncbi.nlm.nih.gov/pubmed/33097077 http://dx.doi.org/10.1186/s13023-020-01585-4

Ejemplares similares

Novel α-1,3-Glucosyltransferase Variants and Their Broad Clinical Polycystic Liver Disease Spectrum
por: Boerrigter, Melissa M., et al.
Publicado: (2023)

Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management
por: Cnossen, Wybrich R, et al.
Publicado: (2014)

Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease
por: Boerrigter, Melissa M., et al.
Publicado: (2023)

Loss of Heterozygosity Is Present in SEC63 Germline Carriers with Polycystic Liver Disease
por: Janssen, Manoe J., et al.
Publicado: (2012)

Ganab Haploinsufficiency Does Not Cause Polycystic Kidney Disease or Polycystic Liver Disease in Mice
por: Geng, Guangrui, et al.
Publicado: (2020)

Large Deletions in GANAB and SEC63 Explain 2 Cases of Polycystic Kidney and Liver Disease
por: Wilson, Elena M., et al.
Publicado: (2020)

GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review
por: De Masi, Roberto, et al.
Publicado: (2022)

Contribution of Genetic and Clinical Risk Factors to Development of Candidemia in Patients Receiving Home Parenteral Nutrition
por: Wouters, Yannick, et al.
Publicado: (2019)

No role for glutathione S-transferase genotypes in Caucasian esophageal squamous cell or adenocarcinoma etiology: an European case–control study
por: Dura, Polat, et al.
Publicado: (2013)

Over-expression of COX-2 mRNA in colorectal cancer
por: Roelofs, Hennie MJ, et al.
Publicado: (2014)

Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls
por: van Heumen, Bjorn WH, et al.
Publicado: (2013)

Prevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control study
por: Kok, Karin F, et al.
Publicado: (2010)

Compound heterozygosity in sodium channel Nav1.7 in a family with hereditary erythermalgia
por: Samuels, Mark E, et al.
Publicado: (2008)

GANAB and PKD1 Variations in a 12 Years Old Female Patient With Early Onset of Autosomal Dominant Polycystic Kidney Disease
por: Waldrop, Elizabeth, et al.
Publicado: (2019)

Polymorphisms in the Insulin-Like Growth Factor Axis Are Associated with Gastrointestinal Cancer
por: Ong, Jennie, et al.
Publicado: (2014)

GANAB as a Novel Biomarker in Multiple Sclerosis: Correlation with Neuroinflammation and IFI35
por: De Masi, Roberto, et al.
Publicado: (2021)

The role of bile salts in liver regeneration
por: van de Laarschot, Liyanne F. M., et al.
Publicado: (2016)

Droplet digital polymerase chain reaction for rapid broad‐spectrum detection of bloodstream infections
por: Wouters, Yannick, et al.
Publicado: (2019)

Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial
por: Wijnands, Titus F. M., et al.
Publicado: (2018)

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues
por: van Aerts, René M. M., et al.
Publicado: (2018)

Polymorphisms in gene encoding TRPV1-receptor involved in pain perception are unrelated to chronic pancreatitis
por: van Esch, Aura AJ, et al.
Publicado: (2009)

Management of portal hypertension and ascites in polycystic liver disease
por: Bernts, Lucas H. P., et al.
Publicado: (2019)

ERVW-1 Activates ATF6-Mediated Unfolded Protein Response by Decreasing GANAB in Recent-Onset Schizophrenia
por: Xue, Xing, et al.
Publicado: (2023)

Infliximab Exerts No Direct Hepatotoxic Effect on HepG2 Cells In Vitro
por: de Vries, Hilbert S., et al.
Publicado: (2012)

Tamoxifen for the treatment of polycystic liver disease: A case report
por: Aapkes, Sophie E., et al.
Publicado: (2021)

Adipocyte abundances of CES1, CRYAB, ENO1 and GANAB are modified in-vitro by glucose restriction and are associated with cellular remodelling during weight regain
por: Qiao, Qi, et al.
Publicado: (2019)

Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease
por: Lee‐Law, Pui Y., et al.
Publicado: (2021)

Estrogen‐Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal Patients
por: van Aerts, René M.M., et al.
Publicado: (2019)

A TGFβ-ECM-Integrin signalling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease
por: Waddell, Scott H, et al.
Publicado: (2023)

Estrogens in polycystic liver disease: A target for future therapies?
por: Aapkes, Sophie E., et al.
Publicado: (2021)

Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease
por: Gevers, Tom JG, et al.
Publicado: (2012)

Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces
por: Venselaar, Hanka, et al.
Publicado: (2010)

Status quo of annotation of human disease variants
por: Venselaar, Hanka, et al.
Publicado: (2013)

Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models
por: Lee-Law, Pui Y., et al.
Publicado: (2020)

Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial
por: Chrispijn, Melissa, et al.
Publicado: (2011)

A Gate Hinge Controls the Epithelial Calcium Channel TRPV5
por: van der Wijst, Jenny, et al.
Publicado: (2017)

Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of Life
por: Duijzer, Renée, et al.
Publicado: (2022)

Functional characterization of TBR1 variants in neurodevelopmental disorder
por: den Hoed, Joery, et al.
Publicado: (2018)

A dsRNA-binding protein of a complex invertebrate DNA virus suppresses the Drosophila RNAi response
por: Bronkhorst, Alfred W., et al.
Publicado: (2014)

Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegaly
por: Barten, Thijs R. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bg5f77d7d329i96p209n12sn9q